Condition: Suicide · Suicidal Ideation · Depression · Sponsor: Lindsay Maguire, MD
There is currently no readily available pharmacologic intervention for suicidal ideation, a true psychiatric emergency, in the Emergency Department (ED). Investigators aim to trial low-dose, intravenous ketamine, a drug with well-established use in treatment-resistant depression, for patients who present to the ED with suicidal ideation.
This description comes directly from the study's public registry record.
Lindsay Maguire, MD · 913-588-3580 · lmaguire@kumc.edu
Lucas Lemar · llemar@kumc.edu
Always discuss trial participation with your own doctor first.
| University of Kansas Strawberry Hill Campus | Kansas City, Kansas, United States | Not Yet Recruiting |
| University of Kansas Medical Center Emergency Department | Kansas City, Kansas, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06085937